Results for “communication delay” — Page 13

NASA NTRSDate not supplied

Information Systems for Crew-Led Operations Beyond Low-Earth Orbit

On past and present human space missions, the management of vehicle health and status has primarily been executed from Earth. Missions such as Apollo, Space Shuttle, and ISS have relied on a safety net of ground-based experts with access to real-time telemetry data, broad and deep systems expertise, and powerful analytical and computing capabilities. The ground team monitors and manages the vehicle’s health in real-time and responds quickly to critical situations and malfunctions. Ground operators also provide real-time oversight and verbal guidance to flight crew members, especially during complex procedure execution and high-risk activities like extra-vehicular activities. However, this operational paradigm, in place for 60 years, will not transfer to long duration exploration missions beyond low Earth orbit (LEO). Lunar and deep-space crewed missions will encounter delayed communications that prohibit real-time operational and medical support. Additionally, there will be infrequent resupply and a diminished capacity to evacuate or rescue crew members. A small crew must operate independently, managing the vehicle’s state, responding to time-critical events, and executing complex procedures, all without the safety net of real-time support.

data representation↗

NASA NTRS2024

Earth Independent Medical Operations [EIMO] Definition Workshop

As the vanguard of human spaceflight increasingly transitions from one of low Earth orbit (LEO) to Lunar and subsequently Martian missions, there is a commensurate imperative for Earth-based medical authority to transition to space-based assets for the continued assurance of optimal astronaut health and performance. The transition to Earth Independent Medical Operations (EIMO) will be a process that enables progressively resilient systems and crews to reduce risk and enhance wellness and overall mission success for deep space exploration. Terrestrial assets will continue to be paramount in pre-mission screening, planning, maintenance, and prevention. Yet on-board care, response to unexpected medical events, and management of communication delays and dropouts will increasingly become the purview of the crew for primary management.

John Lemery↗

NASA NTRS2022

Medical Risk Estimates and Clinical Capability Needs for a Late Artemis Mission

BACKGROUND Human exploration spaceflight missions to the Moon and Mars present unprecedented challenges for in-mission medical care. Compared with the ISS, the greater distance from Earth will mean increased mission durations, communication delays, limited to no resupply opportunities, and significant limitations on the evacuation of ill or injured crew. Spacecraft mass, volume, and power will be curtailed while higher demands will be placed on the crew’s knowledge, skills, and abilities. In this higher risk environment, it is important to: a) quantitatively estimate human system risk attributable to medical conditions, a process known as Probabilistic Risk Analysis, and b) use these estimates to inform medical system design. IMPACT (Informing Mission Planning via Analysis of Complex Tradespaces) is a PRA and medical trade space analysis tool developed by NASA to advance exploration mission medical system design. IMPACT v1.0 improves upon and will soon replace NASA’s existing tool, the Integrated Medical Model, with: a novel evidence base baselined to exploration environments; an expanded list of 119 medical conditions; a significant increase in the number of medical resources that can be utilized and in the flexibility of their use; and the modelling of time lost performing mission-specific tasks due to medical conditions. DISCUSSION: This abstract will present IMPACT estimates of medical system risk and clinical capability needs for an extended duration Artemis mission of approximately 9 months, with phases including outbound transit, 3 months on the Lunar Gateway space station, 3 months on the Lunar surface with EVAs, 3 months on Gateway (simulating the return phase of a Mars mission), and transit back to Earth. Medical system risk estimates include loss of crew life (LOCL), consideration of medical evacuation (known as return to definitive care –RTDC), and an estimate of crew time list due to medical conditions (Task Time Lost –TTL). The presentation will also describe the medical conditions that are the greatest drivers of risk as well as the clinical capabilities and resources that have the largest effect on risk.

A Anderson↗

NASA NTRSDate not supplied

Humans to Mars, but How Many? Using Imprint Human Performance Models to Inform Crew Size

HUMANS TO MARS, BUT HOW MANY? USING IMPRINT HUMAN PERFORMANCE MODELS TO INFORM CREW SIZE Missions to Mars will differ from previous human spaceflight missions in that the onboard crew of astronauts will be required to operate in an Earth-independent manner due to long communication delays. Without a systematic, repeatable process to determine the number and composition of crew necessary to successfully accomplish these missions, NASA increases the risk that crew sizes may be too small to meet primary mission objectives under nominal conditions and, more consequentially, that crewmembers may not have the expertise needed to successfully respond to unforeseen failures without the real-time expertise of the Mission Control Central (MCC) team NASA currently relies upon. The NASA Engineering and Safety Center (NESC) is developing a methodology for assessing the trade space of factors that affect the number of crew for future missions. This methodology includes the consideration of results from three human performance models developed using the Improved Performance Research and Integration Tool (IMPRINT) modeling platform as well as a custom-built model on expertise trained within the crew. The custom-built crew expertise model results will be presented in the training sub-tag. Here we present results of the three IMPRINT models. Two of these models were built using IMPRINT’s Operations Model capability, with detailed task networks for specific systems and scenarios allowing for a comprehensive mental workload analysis on certain crew positions. The third model was built using IMPRINT’s Force Model capability, allowing for a higher-level manpower analysis based on crew engagement in activities performed over a longer Mars transit scenario, and how those activities may be impacted by unplanned events and new tasking unique to the Mars mission. Differences between the models will be presented, as well as examples of model results and a discussion of how those results may inform future Mars mission manpower requirements, system design, and operating procedures.

Donna L Dempsey↗

NASA NTRS2024

Preliminary Medical Risk Estimates and Clinical Capability Needs for Late Artemis Missions

BACKGROUND Human exploration spaceflight missions to the Moon and Mars present unprecedented challenges for in- mission medical care. Compared with the ISS, the greater distance from Earth will mean increased mission durations, communication delays, limited to no resupply opportunities, and significant limitations on the evacuation of ill or injured crew. Spacecraft mass, volume, and power will be curtailed while higher demands will be placed on the crew’s knowledge, skills, and abilities. In this higher risk environment, it is important to: a) quantitatively estimate human system risk attributable to medical conditions, a process known as Probabilistic Risk Analysis, and b) use these estimates to inform medical system design. IMPACT (Informing Mission Planning via Analysis of Complex Tradespaces) is a PRA and medical trade space analysis tool developed by NASA to advance exploration mission medical system design. IMPACT v1.0 improves upon and will soon replace NASA’s existing tool, the Integrated Medical Model, with: a novel evidence base baselined to exploration environments; an expanded list of 119 medical conditions; a significant increase in the number of medical resources that can be utilized and in the flexibility of their use; and the modelling of time lost performing mission-specific tasks due to medical conditions. METHODOLOGY: This abstract will present IMPACT estimates of medical system risk and clinical capability needs for the Artemis IV mission. Artemis IV is currently scheduled for 2026 and will visit the Gateway space station in lunar orbit prior to the second lunar landing of the Artemis program. The baseline Artemis IV mission that was modeled was 28 days in duration with phases including Orion outbound, 4 days on the Gateway space station in lunar orbit, 2 crew on the surface of the Moon for approximately one week, an additional 5 days on Gateway, and then return to Earth. This baseline was compared to two alternative 34-day design reference missions (DRMs) that shifted the lunar sortie earlier or later in the mission profile. Assumptions included 2 female and 2 male crew and a notional medical system mass of 25 kg. Medical system risk estimates include loss of crew life (LOCL), consideration of medical evacuation (known as return to definitive care – RTDC), and an estimate of crew time lost due to medical conditions (Task Time Lost – TTL). The presentation will also describe the medical conditions that are the greatest drivers of risk as well as the clinical capabilities and resources that have the largest effect on risk. RESULTS: All three DRMs had very low probability of LOCL from medical conditions, primarily due to short duration. RTDC was also similar across the DRMs. In contrast, TTL was higher in the early lunar sortie DRM due to earlier occurrence of EVA-related medical conditions. Taken as a whole, there was no clinically significant difference in medical risk across the three missions. Results for clinical capabilities and an example medical equipment list will be discussed but were similar across DRMs.

D. Hilmers↗

NASA NTRSDate not supplied

Humans to Mars, but How Many? Using Training Requirements Modeling to Inform Crew Size

Missions to Mars will differ from previous human spaceflight missions in that the onboard crew of astronauts will be required to operate in an Earth-independent manner due to the long communication delays. Without a systematic, repeatable process to determine the number and composition of crew necessary to successfully accomplish these missions, NASA increases the risk that crew sizes may be too small to meet primary mission objectives under nominal conditions and, more consequentially, that crewmembers may not have the expertise needed to successfully respond to unforeseen failures without the real-time expertise of the Mission Control Central (MCC) team NASA currently relies upon. The NASA Engineering and Safety Center (NESC) is developing a methodology for assessing the trade space of factors that affect the number of crew for future missions. This methodology includes the consideration of results from three human performance models developed using the Improved Performance Research and Integration Tool (IMPRINT) modeling platform as well as a custom-built model on expertise trained within the crew. The IMPRINT results will be presented in the modeling and simulation sub-tag. Here we present results of a model based on NASA’s crew qualification and responsibility matrix (CQRM), a tool used to identify the crew qualifications for each area of responsibility (operation, system, and payload) for a mission. The model outputs an optimized allocation of training assignments along with a flight-assigned CQRM that can be used to consider the expertise that can be trained within a crew of a given size. We discuss the CQRM model result implications on the trade space for Mars mission crew size.

Mars↗

NASA NTRSDate not supplied

Earth Independent Operations Development for NASA’s Mars Campaign Office

NASA’s Moon to Mars Objectives lay out a strategic vision for the future of human spaceflight that culminates in crewed missions to the surface of Mars. The Mars Campaign Office (MCO) of the Moon to Mars Program is responsible for developing the technologies and capabilities necessary to support Mars missions. One such set of technologies supports a need for increased independence from Earth driven primarily by a communications delay between Earth and Mars that can reach twenty minutes or more. This paper lays out the initial strategy and approach for the MCO Earth-Independent Operations (EIO) portfolio and identifies areas targeted for investment between now and Mars missions tentatively planned for the early 2040s.

Ian D Maddox↗

NASA NTRS2024

Crew Health and Performance Integrated Data Architecture (CHP-IDA) TechPort May 2024

Future exploration missions to Mars will have increased need for crew autonomy. Crew Health & Performance (CHP) related data on the ISS is currently, manually downlinked and in disparate locations, which limits crew autonomy for future missions. The CHP-IDA project is developing a backend data system platform that grants the ability to seamlessly collect, store, process, and display CHP-related data for exploration missions. This platform allows for integration of data and advanced analytics that offer crew and ground teams better insight into the crew’s health and performance. It also enables applications that can improve the crew’s ability to provide more autonomous medical care during exploration missions. Data will be collected automatically to reduce crew and ground team time and effort and will synchronize across all in-mission vehicles, habitats, and ground as communication delay permits. The Human Research Program’s (HRP) Medical Data Architecture (MDA) project focused on this backend data architecture but for medical data only. The CHP-IDA project, a joint effort between HRP’s Exploration Medical Capability (ExMC) element and the Exploration Medical Integrated Product Team (XMIPT), expands this capability to all relevant CHP-related data. The additional inputs from nutrition, environment, exercise, radiation, and any other relevant sources will give more insight into crew’s health and performance. Currently, the Human Systems Engineering and Integration Division at Johnson Space Center (JSC) is designing the system. The team completed a system requirements review (SRR) in FY22 and now the focus is on core software development, testbed buildup, and use case scenario demonstration. An end-to-end demonstration with multiple data sources across CHP domains is schedule for the end of FY24 where all three focus areas will be displayed. Following this ground demo, the software will be completed, tested, and validated for flight.

Courtney M Schkurko↗

NASA NTRS2024

Humans to Mars, But How Many? Using Training Qualification Modeling to Inform Number of Crew

Missions to Mars will differ from all previous human spaceflight missions in that the crew of astronauts will be required to operate in an Earth-independent manner due to the long communication delays, making the decision on crew size critical to mission success. To support National Aeronautics and Space Administration (NASA) decision makers, NASA’s Engineering and Safety Center (NESC) developed a quantitative methodology for assessing the number of crew necessary to meet primary mission objectives and respond to unforeseen failures based on modeling of NASA’s crew training qualifications. We present results of a custom-built model of a Mars crew qualification and responsibility matrix (CQRM) and discuss the implications on trade space analysis of Mars mission crew size.

Mars↗

NASA NTRS2024

Humans to Mars, But How Many? Using Training Qualifications Modeling to Inform Number of Crew

Missions to Mars will differ from all previous human spaceflight missions in that the crew of astronauts will be required to operate in an Earth-independent manner due to the long communication delays, making the decision on crew size critical to mission success. To support National Aeronautics and Space Administration (NASA) decision makers, NASA’s Engineering and Safety Center (NESC) developed a quantitative methodology for assessing the number of crew necessary to meet primary mission objectives and respond to unforeseen failures based on modeling of NASA’s crew training qualifications. We present results of a custom-built model of a Mars crew qualification and responsibility matrix (CQRM) and discuss the implications on trade space analysis of Mars mission crew size.

Mars↗

NASA NTRSDate not supplied

Quantifying Medical Risk on a Long Duration Lunar Mission: A Demonstration of NASA’s IMPACT Tradespace Analysis Tool

Background NASA’s human exploration spaceflight missions to the Moon and Mars present unprecedented challenges for in-mission medical care. The distance from Earth will mean increased mission durations, communication delays, limited to no resupply opportunities, and constraints on the medical evacuation of astronauts. Mass, volume, power, and data will be limited while higher demands will be placed on the crew to manage medical care. NASA’s Moon to Mars exploration strategy lays out increasingly complex Artemis missions both in terms of duration and operations. In these more challenging deep space missions, it is important to quantitatively estimate the human medical risk to inform a traditional heuristic approach to medical risk. Prior tools have been developed for missions in low Earth orbit, but a new tool is required to plan for future exploration missions. Methods IMPACT (Informing Mission Planning via Analysis of Complex Tradespaces) is a risk assessment tool developed by NASA to advance exploration mission medical system design by quantitatively estimating mission medical risk. IMPACT v1.0 includes a novel evidence library baselined to exploration environments; an expanded list of 119 medical conditions; the addition of medical resources; and the ability for rapid and iterative analysis. Medical system risk estimates include loss of crew life, consideration of the need for return to definitive care (medical evacuation), and an estimate of crew time affected due to medical conditions. A notional long duration lunar orbit and lunar surface design reference mission (DRM) was chosen with a 4-astronaut crew to represent a sustained exploration Artemis mission. Results/Discussion Overall, IMPACT successfully quantified medical risk and derived an optimized medical system to support crew on a long duration lunar mission. In this DRM, the calculated loss of crew life from a medical event was 0.008 events per mission, risk of potential need for evacuation was 0.30 events per mission, and cumulative crew time affected by medical conditions was 103 days. The medical conditions that most contributed to overall medical risk were decompression sickness, trauma conditions, and respiratory failure. The conditions that had the largest effects on crew performance included musculoskeletal injuries and lunar dust exposure. The IMPACT-generated medical system included resources that target the most common and highest risk conditions. This systematic analysis demonstrates the value of the IMPACT tool in medical system design for human exploration spaceflight missions.

Missions to Mars↗

NASA NTRSDate not supplied

Developing Mars-Based Clinical Scenarios for an Earth Independent Medical Operations (EIMO) – Based Decision Support Service

As crewed missions move beyond Low-Earth Orbit, pre-mission planning cannot fully buy down the medical risks of exploration-class missions. Martian missions, where increased hazards exist, (such as long-duration spaceflight, surface-level EVA operations, and communications delays) will require a paradigm shift in the structure of a medical system. An Earth-Independent Medical Operations-based Medical System (EIMO-MS) will need to optimize four critical domains to help provide medical care: utilization of Pre-Mission Planning, augmentation of Acute and Prolonged Medical Decision Making, automated tracking of Resource Management, and assistance in Task Load Balance. The ideal EIMO-MS will be able to accomplish this goal by having an interactive, adaptable interface that will be able to provide real-time medical services. It must respond based on the level of crewmember training, medical situation, and available medical and non-medical resources. To showcase the capabilities and requirements of such a sophisticated automated MS, a series of clinical scenarios of escalating complexity were developed with clinical and systems engineering input. These scenarios describe in clinical detail what a theoretical future medical system, enhanced with multiple information streams (such as a medical database, an AI-based Decision Support System, real-time monitoring, enhanced in-situ laboratory imaging, etc.) can achieve in conjunction with a trained and experienced crew. Scenarios are comprised of: a context section including objectives and applicable spaceflight environment, a highlighted assumptions section, a clinical narrative section, and a systems engineering activity diagram demonstrating the integrated Medical System (MS). The “swim lanes” of the activity diagram act as the logistical core of each scenario and show how the MS will interact with the crew, ground support, and other in-flight systems. The Design Reference Mission that is used for the scenarios is based on existing reference mission profiles [1] with a projected 30-sol stay on the Martian surface. Scenarios span the spectrum from planned evaluations, minor medical care, urgent care, surgical guidance, critical and expectant management, and behavioral health care. Mission complexity will exponentially increase during deep space and Mars exploration-class missions, and medical support for these missions will likewise need to increase in autonomy and adaptability. The integrated system that will support these missions will need to provide assistance in a variety of anticipated and unforeseen scenarios. These medical scenarios, guided by clinician input, are initial steps in crafting the requirements for an EIMO-based medical system. By working in a systems engineering framework, requirements and capabilities can be extracted and mapped while maintaining a clinical core.

Prashant Parmar↗

NASA NTRS2025

Evaluating the Viability of Compact and Portable X-Ray Systems for an Exploration Medical System in a Ground Demonstration

MOTIVATION FOR INCLUDING X-RAY CAPABILITIES For upcoming exploration missions, the need for enhanced medical care becomes critical due to extended mission durations, significant communication delays, and minimal evacuation opportunities. Previous evidence by our team has revealed that among the 119 medical conditions targeted for management during spaceflight within NASA Exploration Medical Capability’s IMPACT Condition List, at least 36 could benefit from radiography (XR). Utilizing XR for diagnosis and management is hypothesized to significantly improve management of crew health by enabling the immediate evaluation and confirmation of potential injuries or illnesses. Beyond clinical applications, XR also holds potential for non-destructive testing (NDT). This includes applications such as assessing the structural integrity of the spacecraft, analyzing surface and meteorite samples, and inspecting onboard electronics. THREE CANDIDATE X-RAY SYSTEMS CHOSEN FOR GROUND DEMONSTRATION The Exploration Medical Capability Element (ExMC) and the Exploration Medical Integrated Product Team (XMIPT) of the Mars Campaign Office initiated early background work for ground demonstrations. In FY21, ExMC published a Concept of Operations to guide requirements development. By FY23, XMIPT and yet2, a technology scouting and open innovation consulting firm, had completed a market survey and trade study to identify potential miniature XR systems. Selection criteria included commercial-off-the-shelf availability, low mass and volume, and regulatory compliance. The top three candidate devices—Remedi REMEX-KA6, MinXray Impact, and FujiFilm Xair—were acquired to characterize the requirements and capabilities of each device. To facilitate testing, phantoms, and radiographic personal protective equipment (PPE) were purchased, and a dedicated space was designated for XRS usage at Glenn Research Center. During this presentation, the mass, volume, and power requirements for each of the three piloted devices are revealed, as well as information regarding the detector, mA, and kV of the devices. GOAL AND OBJECTIVES OF A MINI XRS GROUND DEMONSTRATION The primary goal of ExMC/XMIPT technology demonstrations is to bridge the gap in available, flight-ready medical device technology by flight-testing diagnostic and treatment technologies essential for managing medical conditions during exploration missions. These technologies must adhere to vehicle constraints such as mass, volume, power, and data requirements, integrate seamlessly with medical decision-support tools, and support increasingly Earth-independent operations. There are three main objectives for the future ground demonstration of these three devices. First, we aim to determine the full capabilities of these three miniature XR systems within the context of the spaceflight environment. While medical applications are the primary focus for the miniature XR, a comprehensive exploration of non-medical uses has been initiated by an XMIPT-sponsored NASA SPARK campaign to identify collaborators. Second, we plan to establish criteria and to use insights gained from evaluating each miniature XR against those criteria to select the most suitable system among the three candidates. Third, we intend to evaluate their suitability for flight certification, which includes assessing its durability for launch, reentry, and exposure to high background radiation, as well as its compatibility with existing data architecture systems. Numerous subject matter experts from NASA and partner institutions will support these objectives.

C A Haddix↗

NASA NTRS2024

Quantifying Medical Risk on a Long Duration Lunar Mission: A Demonstration of NASA’s IMPACT Tradespace Analysis Tool

Background NASA’s human exploration spaceflight missions to the Moon and Mars present unprecedented challenges for in-mission medical care. The distance from Earth will mean increased mission durations, communication delays, limited to no resupply opportunities, and constraints on the medical evacuation of astronauts. Mass, volume, power, and data will be limited while higher demands will be placed on the crew to manage medical care. NASA’s Moon to Mars exploration strategy lays out increasingly complex Artemis missions both in terms of duration and operations. In these more challenging deep space missions, it is important to quantitatively estimate the human medical risk to inform a traditional heuristic approach to medical risk. Prior tools have been developed for missions in low Earth orbit, but a new tool is required to plan for future exploration missions. Methods IMPACT (Informing Mission Planning via Analysis of Complex Tradespaces) is a risk assessment tool developed by NASA to advance exploration mission medical system design by quantitatively estimating mission medical risk. IMPACT v1.0 includes a novel evidence library baselined to exploration environments; an expanded list of 119 medical conditions; the addition of medical resources; and the ability for rapid and iterative analysis. Medical system risk estimates include loss of crew life, consideration of the need for return to definitive care (medical evacuation), and an estimate of crew time affected due to medical conditions. A notional long duration lunar orbit and lunar surface design reference mission (DRM) was chosen with a 4-astronaut crew to represent a sustained exploration Artemis mission. Results/Discussion Overall, IMPACT successfully quantified medical risk and derived an optimized medical system to support crew on a long duration lunar mission. In this DRM, the calculated loss of crew life from a medical event was 0.008 events per mission, risk of potential need for evacuation was 0.30 events per mission, and cumulative crew time affected by medical conditions was 103 days. The medical conditions that most contributed to overall medical risk were decompression sickness, trauma conditions, and respiratory failure. The conditions that had the largest effects on crew performance included musculoskeletal injuries and lunar dust exposure. The IMPACT-generated medical system included resources that target the most common and highest risk conditions. This systematic analysis demonstrates the value of the IMPACT tool in medical system design for human exploration spaceflight missions.

Missions to Mars↗

NASA NTRSDate not supplied

Validation of Self-Scheduling Countermeasures in NASA's HERA Campaign 6

Enhancing crew capabilities for planning and scheduling activities is critical for periods of increased crew autonomy in future long-duration missions where communication delays preclude real-time ground support from Earth. Our study focuses on how to empower astronauts to manage their timelines independently from the experts in the mission control center (MCC). Our objective was to evaluate the impact of scheduling countermeasures on crew scheduling performance, workload, and usability in an analog mission environment. The study involved 16 crew members across four missions in the Limited Autonomy phase of Human Exploration Research Analog (HERA) Campaign 6. Crew members used Playbook to schedule one operational day for the entire crew. Half the participants accessed scheduling aids, and we compared their performance to a control group with no aids. Performance, workload, and usability were assessed using time on task, violation counts, NASA Task Load Index (NASA-TLX), and System Usability Scale (SUS). Participants using scheduling aids completed sessions 20% faster and committed 33% fewer violations. While these differences were not statistically significant due to the study’s operational limitations, trends indicate that scheduling aids may reduce errors and improve efficiency. These results can inform the design of scheduling tools to enhance astronauts’ autonomy in long-duration space missions, contributing to improved crew performance and reduced reliance on ground support.

space robotics↗

NASA NTRSDate not supplied

Validation of Self-Scheduling Countermeasures in NASA's HERA Campaign 6

Enhancing crew capabilities for planning and scheduling activities is critical for periods of increased crew autonomy in future long-duration missions where communication delays preclude real-time ground support from Earth. Our study focuses on how to empower astronauts to manage their timelines independently from the experts in the mission control center (MCC). Our objective was to evaluate the impact of scheduling countermeasures on crew scheduling performance, workload, and usability in an analog mission environment. The study involved 16 crew members across four missions in the Limited Autonomy phase of Human Exploration Research Analog (HERA) Campaign 6. Crew members used Playbook to schedule one operational day for the entire crew. Half the participants accessed scheduling aids, and we compared their performance to a control group with no aids. Performance, workload, and usability were assessed using time on task, violation counts, NASA Task Load Index (NASA-TLX), and System Usability Scale (SUS). Participants using scheduling aids completed sessions 20% faster and committed 33% fewer violations. While these differences were not statistically significant due to the study’s operational limitations, trends indicate that scheduling aids may reduce errors and improve efficiency. These results can inform the design of scheduling tools to enhance astronauts’ autonomy in long-duration space missions, contributing to improved crew performance and reduced reliance on ground support.

space robotics↗

NASA NTRS2025

Humans to Mars, but How Many? Trade Space Analyses for Mars Mission Crew Size

Missions to Mars will differ from previous human spaceflight missions in that the crew of astronauts will be required to operate in an Earth-independent manner due to the long communication delays. Without a systematic, repeatable process to determine the number and composition of crew necessary to successfully accomplish these missions, NASA increases the risk that crew sizes may be too small to meet primary mission objectives under nominal conditions and, more consequentially, that crewmembers may not have the expertise needed to successfully respond to unforeseen failures without the real-time expertise of the Mission Control Central (MCC) team NASA currently relies upon. The NASA Engineering and Safety Center (NESC) developed a methodology for assessing the trade space of factors that affect the number of crew for Mars missions based on human performance and expertise modeling. This methodology includes the consideration of results from three human performance models developed using the Improved Performance Research and Integration Tool (IMPRINT) modeling platform as well as a custom-built model on expertise trained within the crew based on NASA’s crew qualification and responsibilities matrix (CQRM). We present example model results and discuss implications on trade space analyses for Mars mission crew size.

Mars Mission↗

NASA NTRSDate not supplied

Exploration Medical Integrated Product Team Clinical Decision Support Market Survey

NASA’s Exploration Medical Integrated Product Team (XMIPT) has identified Clinical Decision Support (CDS) technology as a critical need for future human space exploration. Such technology will support real time diagnosis, monitoring, and treatment of spaceflight medical conditions. The need for such tools and support systems is critical for in-mission clinical decision-making, especially when Earth-based support is unavailable due to communication delays or blackouts. Supporting technologies may or may not involve Artificial Intelligence (AI), and would support astronaut crew with minimal clinical training, or even those with advanced training if they are, for example, in need of a refresher, experiencing multiple stressors, or temporarily overloaded with tasking. This need traces to the Development of Earth Independent Operations Technologies for NASA’s Mars Campaign Office. The CDS Market Survey purpose, methods, outcomes thus far, and near-term steps will be discussed.

Decision support↗